p3 β-Amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 585-596

  Higgins, Linda S ^a   Murphy Jr , Greer M ^b   Forno, Lysia S ^b,c   Catalano, Rosanne ^a   Cordell, Barbara ^a  

^a Scios Nova Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DYSTROPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; NEURITE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYGDALA; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RABBITS; TAU PROTEINS;

EID: 0030035922     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Hardy J, Allsop D: Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991, 12:383-389
2. Selkoe DJ: Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 1994, 17: 489-517
3. Quon D, Wang Y, Catalane R, Marian Scardina J, Murakami K, Cordell B: Formation of β-amyloid deposits in brains of transgenic mice. Nature 1991, 352:239-241
4. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B: Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neural 1994, 35: 598-607
5. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell A, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Liebowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Sorlano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995, 373:523-527
6. Giaccone G, Tagliavini F, Linoli G, Bouras C, Frigerio L, Frangioni B, Bugiani O: Down syndrome patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989, 97:232-238
7. Mann DMA, Esiri MM: The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989, 89:169-170
8. Motte J, Williams RS: Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down's syndrome brain. Acta Neuropathol 1989, 77:535-546
9. Murphy GM Jr, Eng LF, Ellis WG, Perry G, Meissner LC, Tinklenberg JR; Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease. Brain Res 1990, 537:102-108
10. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Melton A, Oslaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DL, Selkoe DJ: Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992, 359:322-325
11. Shoji M, Golde TE, Ghiso G, Cheung TT, Estus S, Shaffer LM, Cai X-D, McKay LM, Tinter R, Frangione B, Younkin SG: Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992, 258:126-129
12. Busciglio J, Gabduzda DH, Yankner BA: Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells. Proc Natl Acad Sci USA 1993, 90: 2092-2096
13. Zhong Z, Higaki J, Murakami K, Wang Y, Catalano R, Quon D, Cordell B: Secretion of β-amyloid precursor protein involves multiple cleavage sites. J Biol Chem 1994, 269:627-632
14. Higaki J, Quon D, Zhong Z, Cordell B: Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 1995, 14: 651-659
15. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K: Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989, 57:115-126
16. Palmert MR, Podlisny MB, Witker DS, Oltersdorf T, Younkin LH, Selkoe DJ, Younkin SG: The β-amyloid protein precursor of Alzheimer's disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 1989, 86:6338-6342
17. Podlisny MB, Mammen AL, Schlossmacher MG, Palmert MR, Younkin SG, Selkoe DJ: Detection of soluble forms of the β-amyloid precursor protein in human plasma. Biochem Biophys Res Commun 1990, 167: 1094-1101
18. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ: Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 1990, 248:1122-1124
19. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ: β-Amyloid peptide and a 3 kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 1993, 268:3021-3024
20. Landsbury PT Jr: In pursuit of the molecular of amyloid plaque: new technology provides unexpected and critical information. Biochemistry 1992, 31:6865-6870
21. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW: Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 1995, 64:253-265
22. Castano EM, Ghiso J, Prelli F, Gorevic PD, Migheli A, Frangions B: In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimers disease β-protein. Biochem Biophys Res Commun 1989, 141:782-789
23. Kirschner DA, Inouyae H, Duffy LK, Sinclair A, Lind M, Selkoe DJ: Synthetic peptide homologous to β protein from Alzheimer's disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 1987, 84:6953-6957
24. Gorevic PD, Castano EM, Sarma R, Frangione B: Ten to fourteen residue peptide of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun 1987, 147:854-862
25. Barrow CJ, Zagorski MG: Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 1991, 253:179-182
26. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K: Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J Mol Biol 1991, 218:149-163
27. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C: Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 1992, 267:546-554
28. Barrow CJ, Yasuda A, Kenny PTM, Zagorski MG: Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J Mol Biol 1992, 225:1075-1093
29. Jarrett JT, Berger E, Landsbury PT Jr: The carboxy terminus of the β-amyloid protein is critical for seeding of amyloid formation; implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697
30. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K: Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptides. J Mol Biol 1992, 224:460-473
31. Halverson K, Fraser PE, Kirschner DA, Landsbury PT Jr: Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry 1990, 29: 2639-2644
32. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 1990, 250:279-282
33. Busciglio J, Lorenzo A, Yankner BA: Methodological variables in the assessment of β-amyloid neurotoxicity. Neurobiol Aging 1992, 13:609-612
34. Pike CJ, Burdick D, Walencewicz AJ, Glade CG, Cotman CW: Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993, 13:1676-1687
35. Lorenzo A, Yankner BA: β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 1994, 91:12243-12247
36. Loo DT, Copani A, Pike CJ, Whittemore ER. Walencewicz AJ, Cotman CW: Apoptosis in induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993, 90:7951-7955
37. Forloni G, Chiesa R, Smiroldo S, Verga L, Salmona M, Tagliavini F, Angeretti N: Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35. NeuroReport 1993, 4:523-526
38. Koh J-Y, Yang LL, Cotman CW: β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990, 533:315-320
39. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE: β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992, 12:376-389
40. Copani A, Kho J-Y, Cotman CW: β-Amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport 1991, 2:763-765
41. Meda L, Cassatella MA, Szendrel GI, Otvos L Jr, Baron L, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by β-amyloid protein, and interferon-γ. Nature 1995, 374:647-650
42. Murphy GM Jr, Greenberg BD, Ellis WG, Forno LS, Salamat SM, Gonzalez-DeWhitt PA, Lowery DE, Tinklenberg JR, Eng LF: β-Amyloid precursor protein expression in the nucleus basalis of Meynert. Am J Pathol 1992, 141:357-361
43. Murphy GM Jr, Forno LS, Higgins L, Scardina JM, Eng LF, Cordell B: Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its Immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994, 144: 1082-1088
44. Arai H, Lee VM-Y, Otvos L, Greenberg BD, Lowery DF, Sharma SK, Schmidt ML, Trojanowski JQ: Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci USA 1990, 87:2249-2253
45. Yamaguchi H, Ishiguro K, Shoji M, Yamazaki T, Nakazato Y, Ihara, Y Hirai S: Amyloid β/A4 protein precursor is bound to neurofibrillary tangles in Alzheimer-type dementia Brain Res 1990, 537:318-322
46. Joachim C, Games D, Morris J, Ward P, Frenkel D, Selkoe D: Antibodies to non-β regions of the β-amyloid precursor protein detect a subset of senile plaques. Am J Pathol 1993, 138:373-384
47. Cole GM, Masliah E, Shelton ER, Chan HW, Terry RD, Saitoh T: Accumulation of amyloid precursor fragment in Alzheimer plaques. Neurobiol Aging 1991, 12:85-95
48. Perry G, Richey PL, Siedlak SL, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN: Immunocytochemical evidence that the β-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1993, 143:1586-1593
49. Wong CW, Quaranta V, Glenner GG: Neuritic plaques d cerebrovascular amyloid in Alzheimer's disease are antigenically related. Proc Natl Acad Sci USA 1985, 82:8729-8732
50. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 1985, 82:4245-4249
51. Mori H, Takio K, Ogawara M, Selkoe DJ: Mass spectrometry of purified amyloid βprotein in Alzheimer's disease. J Biol Chem 1992, 267:17082-17086
52. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Göwing E, Ball MJ: β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:10836-10840
53. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ: Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J Biol Chem 1994, 269: 10987-10990
54. Masliah E, Hansen L, Albright T, Mallory M, Terry R: Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol 1991, 81:428-433
55. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk D: Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993, 61:1965-1968
56. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilo-Gambetti L, Gambetti P: Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994, 200:1598-1603
57. Buee L, Ding WE, Anderson JP, Narindrasorasak S, Kisilevsky R, Boyle NJ, Robakis NK, Delacourt A, Greenberg BD, Fillit HM: Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res 1993, 627:199-204
58. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:1977-1981
59. Naidu A, Quon D, Cordell B: β-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J Biol Chem 1995 270:1369-1374
60. Terry R, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580